s41380-018-0107-4.pdf (1.49 MB)
Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
journal contribution
posted on 2023-06-09, 14:05 authored by Samuel Turton, James FM Myers, Inge Mick, Alessandro ColasantiAlessandro Colasanti, Ashwin Venkataraman, Claire Durant, Adam Waldman, Alan Brailsford, Mark C Parkin, Gemma Dawe, Eugenii A Rabiner, Roger N Gunn, Stafford L Lightman, David J Nutt, Anne Lingford-HughesAddiction has been proposed as a ‘reward deficient’ state, which is compensated for with substance use. There is growing evidence of dysregulation in the opioid system, which plays a key role in reward, underpinning addiction. Low levels of endogenous opioids are implicated in vulnerability for developing alcohol dependence (AD) and high mu-opioid receptor (MOR) availability in early abstinence is associated with greater craving. This high MOR availability is proposed to be the target of opioid antagonist medication to prevent relapse. However, changes in endogenous opioid tone in AD are poorly characterised and are important to understand as opioid antagonists do not help everyone with AD. We used [11C]carfentanil, a selective MOR agonist positron emission tomography (PET) radioligand, to investigate endogenous opioid tone in AD for the first time. We recruited 13 abstinent male AD and 15 control participants who underwent two [11C]carfentanil PET scans, one before and one 3?h following a 0.5?mg/kg oral dose of dexamphetamine to measure baseline MOR availability and endogenous opioid release. We found significantly blunted dexamphetamine-induced opioid release in 5 out of 10 regions-of-interest including insula, frontal lobe and putamen in AD compared with controls, but no significantly higher MOR availability AD participants compared with HC in any region. This study is comparable to our previous results of blunted dexamphetamine-induced opioid release in gambling disorder, suggesting that this dysregulation in opioid tone is common to both behavioural and substance addictions.
History
Publication status
- Published
File Version
- Published version
Journal
Molecular PsychiatryISSN
1359-4184Publisher
Nature Publishing GroupExternal DOI
Department affiliated with
- BSMS Neuroscience Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2018-07-06First Open Access (FOA) Date
2018-07-06First Compliant Deposit (FCD) Date
2018-07-05Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC